OpGen

OpGen Equity Ratio

The Equity Ratio of OpGen (OPGN) as of Oct 19, 2026 is 83.71 %. In the previous year, Equity Ratio was 74.83 % — a change of 11.86% (higher).

Equity Ratio

83.71 %

YoY

11.86%

Last updated:

Equity Ratio of OpGen is 2025 83.71 % . Equity Ratio of OpGen was 2024 74.83 % . It decreases by 11.86% higher compared to the previous year.

The OpGen Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
36.97 USD
Jan 1, 2019
41.20 USD
Jan 1, 2020
42.59 USD
Jan 1, 2021
57.51 USD
Jan 1, 2022
29.33 USD
Jan 1, 2023
-614.23 USD
Jan 1, 2024
74.83 USD
Jan 1, 2025
83.71 USD
The OpGen Equity Ratio history
YEAREquity RatioYoY
83.71 %+11.86%
74.83 %-112.18%
-614.23 %-2,194.27%
29.33 %-49.00%
57.51 %+35.02%
42.59 %+3.40%
41.20 %+11.44%
36.97 %+74.68%
21.16 %-39.97%
35.26 %-35.23%
54.43 %-117.92%
-303.80 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OpGen Stock analysis

What does OpGen do? OpGen Inc is a biotechnology company based in Gaithersburg, Maryland, operating within the Health Care sector. The company went public on May 5, 2015, with ticker OPGN and ISIN US68373L5057. It currently employs three people. OpGen develops molecular information solutions focused on combating infectious diseases in global healthcare settings. The company's technology involves DNA tests and bioinformatics to address antibiotic resistance, assisting healthcare providers in managing patient care decisions and monitoring the spread of multidrug-resistant microorganisms. Its solutions aim to guide clinicians with information about life-threatening infections and help manage patient outcomes. The company's website is http://opgen.com/. OpGen is engaged in creating tools to help protect the hospital biome through customized screening and surveillance. The firm markets its high-resolution DNA tests under the Acuitas trade name. The company has a global network of customers and partners. OpGen does not provide specific details on its product names beyond Acuitas, and no additional financial figures or historical data are available in the provided information. OpGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OpGen stock

Equity Ratio of OpGen is 83.71 % in 2025.

Equity Ratio of OpGen changed from 74.83 % to 83.71 %, representing a 11.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio OpGen since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's OpGen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — OpGen

All Key Metrics — OpGen